| Literature DB >> 30962044 |
Lorenzo Galluzzi1, Guido Kroemer2.
Abstract
Glucocorticoids (GCs) are widely used for the management of disease- or therapy-related complications in cancer patients. Recent data indicate that activation of GC receptors (GRs) precipitates breast cancer progression by favoring metastatic dissemination and cell survival at distant sites. These findings call for the re-evaluation of GC usage in patients with cancer.Entities:
Keywords: ROR1; circulating tumor cells; dormancy; immunotherapy; social stress; triple negative breast cancer
Mesh:
Substances:
Year: 2019 PMID: 30962044 DOI: 10.1016/j.tcb.2019.03.005
Source DB: PubMed Journal: Trends Cell Biol ISSN: 0962-8924 Impact factor: 20.808